SVLSF IV, LLC Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for SVLSF IV, LLC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of SVLSF IV, LLC. SVLSF IV, LLC is a 10% Owner in KalVista Pharmaceuticals, Inc. ($CBYL) and a 10% Owner in ENTELLUS MEDICAL INC ($ENTL) and a 10% Owner in OCULAR THERAPEUTIX, INC ($OCUL) and a 10% Owner in NeurogesX Inc ($NGSX).

Address: 60 STATE STREET, SUITE 3650 BOSTON 02109 MA

Companies in which SVLSF IV, LLC is an Insider

ENTELLUS MEDICAL INC

Trading Symbol: ENTL
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of SVLSF IV, LLC: 10% Owner
Holdings: 1,091,166 shares
Current Value: $18,462,529
Latest Transaction: Feb 02 2017
$ENTL Market Capitalization: $316.35M
$ENTL Previous Close: $16.92

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

KalVista Pharmaceuticals, Inc.

Trading Symbol: KALV
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of SVLSF IV, LLC: 10% Owner
Holdings: 1,698,554 shares
Latest Transaction: Apr 10 2019

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

NeurogesX Inc

Trading Symbol: NGSX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of SVLSF IV, LLC: 10% Owner
Holdings: 61,324 shares
Latest Transaction: May 05 2010

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

OCULAR THERAPEUTIX, INC

Trading Symbol: OCUL
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of SVLSF IV, LLC: 10% Owner
Holdings: 61,084 shares
Current Value: $422,090
Latest Transaction: Jun 11 2015
$OCUL Market Capitalization: $171.42M
$OCUL Previous Close: $6.91

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of SVLSF IV, LLC

Sentiment: All, ENTL, KALV, NGSX, OCUL

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Apr 10 2019KALVKalVista Pharmaceu ...SVLSF IV, LLC10% OwnerSellS29.4037410,99447,47147.8 K to 47.5 K (-0.78 %)
Apr 10 2019KALVKalVista Pharmaceu ...SVLSF IV, LLC10% OwnerSellS29.4013,157386,7531,672,1051.7 M to 1.7 M (-0.78 %)
Apr 10 2019KALVKalVista Pharmaceu ...SVLSF IV, LLC10% OwnerSellS28.5337710,75647,84548.2 K to 47.8 K (-0.78 %)
Apr 10 2019KALVKalVista Pharmaceu ...SVLSF IV, LLC10% OwnerSellS28.5313,292379,2271,685,2621.7 M to 1.7 M (-0.78 %)
Apr 10 2019KALVKalVista Pharmaceu ...SVLSF IV, LLC10% OwnerSellS29.4962918,55048,22248.9 K to 48.2 K (-1.29 %)
Apr 10 2019KALVKalVista Pharmaceu ...SVLSF IV, LLC10% OwnerSellS29.4922,171653,8651,698,5541.7 M to 1.7 M (-1.29 %)
Apr 02 2019KALVKalVista Pharmaceu ...SVLSF IV, LLC10% OwnerSellS28.762537,27748,85149.1 K to 48.9 K (-0.52 %)

View all SVLSF IV, LLC insider transactions.